Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLC1501 in stroke recovery
NCT05289947Phase 2Completed
- Sponsor
- Moleac
- Start
- Jul 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of MLC1501 in ischemic stroke, sponsored by Moleac. Started Jul 2023; status: completed.
02
Drugs
MLC1501
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05289947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05289947.